As the obesity-inflammation-aromatase axis plays crucial roles in tumorigenesis in postmenopausal luminal breast cancer5, further study is warranted to elucidate the detailed mechanism on the effect of postmenopausal HRT use on the clinical outcome of luminal breast cancer. This evidence concerns the gene CYP19A1 and breast carcinoma.